Pediatric anesthesia & critical care
Intravenous dexamethasone does not prolong the duration of pudendal nerve block in infants and children undergoing hypospadias surgery: A randomized clinical trial
Primary result · Time to first PCA-by-proxy bolusResult — go to the resultHazard ratio 0.8 95% CI 0.43–1.47Authors' conclusion
Administration of intravenous dexamethasone did not enhance the duration of pudendal nerve block in infants and children aged 6-36 months who underwent hypospadias surgery.
Study context
- Population
- Children aged 6–36 months undergoing hypospadias surgery with bilateral pudendal block (0.3 mL/kg 0.225% ropivacaine)
- Participants
- 46 children
- Comparison
- IV dexamethasone 0.5 mg/kg vs normal saline with pudendal block
- Primary endpoint
- Time to first PCA by proxy bolus dose
Primary result
Time to first PCA-by-proxy bolus
Hazard ratio
0.8
95% CI 0.43–1.47
P = 0.46
By group
Control vs Dexamethasone
HR 0.8 (95% CI 0.43–1.47); P = 0.46
As reported in the abstract
Secondary outcomes
Pain score, number of PCA by proxy bolus attempts, rescue analgesics, total fentanyl, parental satisfaction
- No statistically significant differences
Original publication
Intravenous dexamethasone does not prolong the duration of pudendal nerve block in infants and children undergoing hypospadias surgery: A randomized clinical trial. Paediatr Anaesth. Published 1 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →